Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Buy
69,801
+4,297
+7% +$160K ﹤0.01% 2383
2026
Q1
$2.31M Buy
65,504
+2,466
+4% +$108K ﹤0.01% 2226
2025
Q4
$3.09M Sell
63,038
-994
-2% -$41.7K ﹤0.01% 2122
2025
Q3
$3.09M Hold
64,032
﹤0.01% 2125
2025
Q2
$1.96M Sell
64,032
-12,872
-17% -$346K ﹤0.01% 2309
2025
Q1
$2.05M Sell
76,904
-36,848
-32% -$1.1M ﹤0.01% 2331
2024
Q4
$3.82M Sell
113,752
-215,172
-65% -$9.52M ﹤0.01% 2098
2024
Q3
$14.8M Sell
328,924
-97,019
-23% -$3.28M ﹤0.01% 1378
2024
Q2
$8.9M Buy
425,943
+316,860
+290% +$4.74M ﹤0.01% 1646
2024
Q1
$1.44M Sell
109,083
-112,760
-51% -$1.2M ﹤0.01% 2544
2023
Q4
$2.48M Buy
221,843
+146,890
+196% +$1.74M ﹤0.01% 2314
2023
Q3
$1.08M Buy
74,953
+3,907
+5% +$68.3K ﹤0.01% 2545
2023
Q2
$1.35M Buy
+71,046
New +$1.56M ﹤0.01% 2520
2021
Q2
Sell
-90,102
Closed -$608K 3449
2021
Q1
$608K Sell
90,102
-4,073
-4% -$33.4K ﹤0.01% 3054
2020
Q4
$646K Buy
94,175
+1,360
+1% +$7.67K ﹤0.01% 2961
2020
Q3
$519K Buy
92,815
+476
+0.5% +$2.86K ﹤0.01% 2944
2020
Q2
$481K Buy
+92,339
New +$454K ﹤0.01% 2915

Other funds holding HROW

Nuveen's HROW Position: Q2 2026 in Review

Nuveen increased its Harrow (HROW) stake by 6.6% in Q2 2026, buying an estimated $160K and bringing the position to 69,801 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

Nuveen first reported a position in HROW in Q2 2020 and has held it in 17 quarters since. The position peaked at $14.8M in Q3 2024. 223 funds tracked by Wall St. Rank hold HROW as of Q2 2026.

  • Nuveen held 69,801 shares of Harrow worth $2.96M as of Q2 2026.
  • Nuveen bought 4,297 Harrow shares in Q2 2026, an estimated $160K.
  • Harrow made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2383 holding.
  • Nuveen first reported a position in Harrow in Q2 2020 and has held it in 17 quarters since.
  • Nuveen's Harrow position peaked at $14.8M in Q3 2024.
  • 223 funds tracked by Wall St. Rank held Harrow as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.